Corcept's ovarian cancer combination drug meets main goal in late-stage study-March 2024-www.financetom.com

Corcept's ovarian cancer combination drug meets main goal in late-stage study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Corcept's ovarian cancer combination drug meets main goal in late-stage study

Mar 31, 2025 5:22 AM

March 31 (Reuters) - Corcept Therapeutics ( CORT ) said

on Monday its experimental ovarian cancer drug in combination

with chemotherapy met the main goal of a late-stage trial.

Previous page： Expect margin to normalise in the coming quarters as focus to remain on growth, says Nazara Tech Next page： Honeywell Automation sees double-digit orderbook growth; expects demand uptick from renewables

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Expect margin to normalise in the coming quarters as focus to remain on growth, says Nazara Tech

Aug 2, 2021

Nazara Technologies is back in the black and the company’s revenue during the quarter ended June 2021 saw a 45 percent growth led by e-sports and Gamified Early Learning. The e-sports segment’s revenue doubled to Rs 53.2 crore, while that of Gamified Early Learning segment grew about 46 per cent to Rs 52.1 crore in the June 2021 quarter from the year-ago period.

Honeywell Automation sees double-digit orderbook growth; expects demand uptick from renewables

Jul 28, 2021

Honeywell Automation expects an uptick in demand from the renewable energy portfolio, Ashish Gaikwad, managing director (MD), told CNBC-TV18.

Nothing launches wireless earbuds Nothing Ear (1) at Rs 5,999

Jul 27, 2021

Carl Pei’s consumer tech company Nothing launched its first product Nothing Ear (1), wireless earbuds, on July 27.

Google to launch own processor for upcoming Pixel phones

Aug 3, 2021

Alphabet Inc's Google will use processors designed in-house for its new Pixel phones launching later this fall, in a shift away from Qualcomm Inc's technology that has powered the tech giant's Android devices for more than 15 years. The processor, called Tensor, will power the Pixel 6 and Pixel 6 Pro phones.